The most useful question about Bliv is not simply whether its advertised monthly price looks affordable. It is what you would actually be buying: an evaluation, a recurring service, a particular prescription or a financed package. Bliv advertises several different starting amounts, while its terms place the final price, billing frequency and included services at checkout. Before comparing it with another program, a prospective patient needs those pieces assembled into one written offer.
Bliv presents itself as a U.S. telehealth platform facilitating GLP-1 evaluations and prescriptions, including advertised semaglutide and tirzepatide options. This documentary review examines public pages consulted October 19, 2026, including terms and policies identifying an October 15, 2026 effective date. The documents provide meaningful detail about clinical responsibilities, automatic renewal and medication refunds. They do not establish the formulation, route, supply quantity or complete cost of a particular order. The practical goal is to identify what Bliv explains already—and what to ask before authorizing payment.
At a glance
- Who provides care
- Metabody Services, LLC operates the Bliv platform; Metabody Medical P.A. and affiliated professional entities provide clinical services.Sources: [5]
- Advertised medication prices
- Semaglutide is advertised as low as $116 per month and tirzepatide as low as $199 per month, each depending on plan structure and eligibility.Sources: [3]
- Compounded medication disclosure
- The commercial page describes medications as compounded; the terms say some may be compounded. The exact product for an individual order needs confirmation.
- Automatic renewal
- Paid subscriptions renew at the then-current price until canceled. Canceling a subscription does not itself cancel a pending prescription, laboratory order or appointment.Sources: [5]
- Medication refund boundary
- Medication is not charged before prescription approval. A full refund is available before transmission to the pharmacy; after transmission, medication is generally nonrefundable.Sources: [5]
Start by identifying the team responsible for your care
Bliv is the consumer-facing brand, but its terms distinguish the platform operator from the treating organization. The contracting company, Metabody Services, LLC, describes itself as a technology and management services company—not a healthcare provider. Evaluations, diagnoses, treatment plans, prescriptions, laboratory orders, refills and follow-up belong to Metabody Medical P.A. and affiliated professional entities, through the licensed clinicians they employ or engage. That distinction matters when asking who can answer a medical question or change a treatment plan.
The terms assign separate medical entities to California, New Jersey and New York, Kansas, Colorado and Texas, with Metabody Medical P.A. assigned to other states. However, that organizational list is not an unconditional availability guarantee: clinical services depend on having licensed clinicians in the state, and Bliv reserves the ability to restrict or discontinue services. Users must be at least 18, able to contract, and both resident and physically located in the United States when using the services.
Ask which medical group would treat you, whether it currently serves your location, and how to contact its clinical team separately from billing support. Bliv advertises board-certified clinicians, but the consulted documentation does not independently verify an individual clinician’s credentials. A clinician is not necessarily a physician. The broader questions to settle before enrollment are particularly useful here: identify the responsible professionals before treating the platform’s brand as a complete description of care.
What happens after the online intake?
Bliv’s commercial page describes a medical intake reviewed securely by a U.S.-licensed provider, with no phone call or video visit. It says a licensed clinician reviews health information and, if appropriate, usually writes a prescription within a day. That is an advertised workflow and typical timing, not guaranteed approval. The terms explicitly say requesting a service does not guarantee acceptance as a patient, an evaluation, a prescription or any particular outcome.
The clinician can request additional information, laboratory testing or an in-person visit, decline treatment or discontinue it using professional judgment. Before clinical services, patients must consent to telehealth and acknowledge the medical groups’ privacy notice. The linked telehealth-consent text was not available in the consulted material, so its state-specific provisions cannot be assessed here. Ask how additional evaluation would be arranged and charged if the initial questionnaire does not resolve the clinician’s questions.
Bliv does not publish complete GLP-1 eligibility criteria in these documents, including specific BMI thresholds or all exclusions. Do not interpret the adult age requirement as medical eligibility. For the intake, prepare an accurate medication and supplement list, allergies, relevant history and pregnancy plans for discussion with the clinician. NIDDK identifies these as important consultation topics; this review cannot determine whether either advertised medication is appropriate for a particular person.
Ask for the exact medication, not just its ingredient name
Bliv advertises semaglutide and tirzepatide, but the consulted pages do not settle the route of administration, presentation, concentration, additional ingredients or supply quantity for an individual order. There is also a wording difference worth resolving: the commercial page says medications prescribed through Bliv are compounded and dispensed by licensed U.S. pharmacies, while the terms say some medications may be compounded. Neither statement supplies a complete product description for the prescription you might receive.
The terms say a clinician will prescribe a compounded medication only when considered clinically appropriate and will discuss the reasons with the patient. They also state that compounded medications are not FDA approved and do not receive FDA premarket verification of safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug. That recommendation is not a blanket legal conclusion, and nonapproval alone does not establish clinical inequivalence.
Request the full product description and the clinician’s explanation before purchase, using these medication-identification questions as a checklist. Bliv’s promotional descriptions of stronger appetite control or faster results for tirzepatide remain commercial claims, not measured outcomes from this service. Without an identified product, formulation and route, research involving a particular approved product should not be treated as proof of what a Bliv order will deliver or how an individual will respond.
Turn the advertised amounts into a complete written quote
Bliv displays several figures that cannot safely be combined into one treatment price. Semaglutide starts as low as $116 per month and tirzepatide as low as $199 per month, both conditioned on plan structure and eligibility. A separate consultation headline starts as low as $58 per month. The page also advertises a limited-time 50% discount without identifying, in the consulted passage, its qualifying product, reference price or duration. These are documented offers, but not interchangeable descriptions of one package.
Financing is another separate layer: Bliv advertises payments as low as $29 per month on eligible plans, CareCredit at 0% over 24 months and Klarna split payments. Its approval language is promotional; plan structure and eligibility still apply. The consulted material does not identify the financed principal or complete repayment total. A financing installment is not necessarily the cost of one month’s medication, and it does not establish what happens to repayment obligations if treatment ends.
Ask for an itemized quote showing the initial charge, subsequent charges, billing interval, included medication quantity, evaluation fee, laboratory costs and any supplies. The terms say purchase-screen details govern price, renewal and inclusions. They do not establish that every advertised minimum requires upfront payment—or that none does. Our price questions beyond the monthly amount can help separate the service price from the payment schedule before you authorize either.
| Advertised item | Documented condition | Question before payment |
|---|---|---|
| Semaglutide: as low as $116/month | Depends on plan structure and eligibility | Which formulation, quantity and billing arrangement qualify? |
| Tirzepatide: as low as $199/month | Depends on plan structure and eligibility | What is included, and what will subsequent charges be? |
| Consultation headline: as low as $58/month | The headline does not identify the complete package | How does this relate to the medication prices? |
| Financing: as low as $29/month | Eligible plans; CareCredit and Klarna advertised | What principal, repayment schedule and total apply? |
| Limited-time 50% off | Qualifying product and reference price are unspecified | What receives the discount, and when does it end? |
Follow the prescription through the pharmacy and delivery process
The medical groups select licensed U.S. pharmacies or outsourcing facilities to fill prescriptions. These partners are independent of Metabody Services, LLC, and dispensing is subject to their terms and state pharmacy law. The consulted pages do not name the pharmacy that would handle a particular order. Bliv says the preparing pharmacy’s name and contact information appear on the prescription label and in order details. Ask when that identity becomes available and where product-specific questions should go.
Bliv advertises free shipping in discreet packaging, typically within three to five days. That wording does not clearly establish whether the clock starts at approval, pharmacy transmission or dispatch, and it is separate from the advertised one-day clinical review. Shipments go only to the U.S. address provided. The terms make patients responsible for accurate address information, receipt and proper storage, and disclaim responsibility for certain carrier, weather or post-delivery handling problems. Prescription products cannot be returned.
There is nevertheless a specific remedy for a shipment arriving damaged, incorrect or unusable: notify Bliv within seven days, and it says it will arrange a replacement without charge. Ask how to document a problem and reach the pharmacy promptly. If an injectable GLP-1 product arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. That advice is relevant if the prescribed product is injectable; Bliv’s reviewed pages do not establish every order’s route.
Define follow-up before the first refill is due
Bliv promises individualized assessments and ongoing clinical support, but the consulted passage does not specify scheduled follow-up frequency, clinical response times or refill requirements. It also advertises phone support without stating support hours. Ask who reviews tolerance and response, how to reach that person, whether follow-up is scheduled or patient-initiated, and what services cost extra. An ongoing-support statement is useful, but it does not by itself explain how a concern reaches the treating clinician.
Laboratory testing, when ordered, is handled by independent laboratories described in the terms as CLIA-certified. Results go through the platform and to the clinician; the laboratories’ terms govern collection and testing. Bliv also advertises a Skool community with nutrition guidance led by a dietetics professional and a peer forum. The consulted passage does not establish its price, frequency or whether access is included in a particular plan. Neither a forum nor general nutrition guidance specifies the medical follow-up arrangement.
The AI assistant has a different role again: Bliv says it does not provide medical advice, diagnosis or treatment, prescribe, or make clinical decisions. Ask how a question moves from automated assistance to a licensed clinician, particularly outside ordinary support hours. NIDDK emphasizes follow-up for treatment response and tolerability, not merely continued payment. A practical care plan should explain that clinical process rather than leaving patients to infer it from access to messaging, community features or an assistant.
Separate stopping renewal from canceling an order
Bliv advertises no long-term commitments or cancellation fees, but its terms still create an ongoing billing arrangement for paid subscriptions. They renew automatically at the end of each billing period at the then-current price until canceled. Cancellation is available through account settings, the relevant app-store subscription settings or support. It takes effect at the end of the current billing period, with access continuing until then. Importantly, it does not automatically cancel pending prescription orders, laboratory orders or clinical appointments.
Refund rights depend on what was purchased and how far the process has progressed. If the clinician declines treatment or determines you are not a candidate, the evaluation fee is refunded in full. Once evaluation is complete and treatment has been offered, that fee is generally nonrefundable unless purchase terms say otherwise. Medication is not charged before prescription approval; a full medication refund is available before transmission to the pharmacy. After transmission, medication is nonrefundable under the stated policy.
Subscription, program and AI-credit charges generally are not refunded or prorated, subject to stated legal or purchase exceptions. Unused prepaid amounts are refundable if Bliv terminates an account without cause or discontinues a paid service in the patient’s state. Approved refunds are issued to the original payment method within ten business days—not guaranteed to appear in the bank within that period. Before enrolling, use these renewal and cancellation questions to confirm how to stop each separate transaction.
Check payment, privacy and contact arrangements together
Bliv’s terms describe clinical care and prescriptions as self-pay. Unless expressly stated otherwise, neither the operator nor medical groups bill insurance, Medicare or Medicaid. Possible health-plan reimbursement or HSA/FSA use is not guaranteed. This wording does not establish a blanket exclusion of people with government insurance; it describes billing responsibility. Ask what receipts are available and confirm any reimbursement or account eligibility separately rather than treating platform payment acceptance as an insurance benefit.
The privacy policy says identifiable personal information—including health information and AI-assistant conversations—is not used to train AI models. It permits de-identified data to evaluate, fine-tune and improve its own models and features. The medical privacy notice says most records are available through the account; other copies can be requested from the privacy officer. It specifies a response within 30 days, with one additional 30-day extension on notice, and allows a reasonable cost-based copying fee.
For practical contact, the terms list 888-859-2882 and Metabody Services, LLC, 2943 Parkway Blvd, Unit 374, West Valley City, UT 84119. Email addresses were masked in the consulted text, so this review cannot provide a verified support email. Confirm the working clinical, billing and privacy contact routes before payment. The documentation also does not confirm Spanish-language care or interpretation; the terms say the English-language version controls. Anyone needing language assistance should resolve that before relying on the intake process.
Questions & answers
Is Bliv itself the medical provider?
No. Its terms identify Metabody Services, LLC as the technology and management company operating the platform. Clinical services come from Metabody Medical P.A. and affiliated professional entities through their clinicians. Ask which group and clinician would be responsible for your care, because platform customer support and the treating clinical team have different responsibilities.
Can I assume the $58 headline covers my medication?
No. The consultation headline advertises a starting amount of $58 per month without enough detail to establish a complete medication package. Separate listings advertise semaglutide from $116 and tirzepatide from $199 per month, conditioned on plan structure and eligibility. Request a written explanation of which offer applies and what the initial and recurring charges include.
Will Bliv require a video appointment?
Its advertised intake says no phone calls or video visit, with review by a licensed provider. However, the terms allow clinicians to request more information, laboratory testing or an in-person visit. The online questionnaire therefore does not guarantee that every person can complete evaluation and receive a prescription without additional steps.
Can I choose my own dispensing pharmacy?
The consulted terms describe pharmacies or outsourcing facilities selected by the medical groups, not an unrestricted patient-choice arrangement. They say the preparing pharmacy’s name and contact information appear on the label and in order details. Ask about pharmacy choice and when its identity is disclosed before assuming a prescription can go to your preferred pharmacy.
What happens if the pharmacy cannot fill my prescription?
Bliv’s terms provide a full refund of the medication charge or, if you prefer, an alternative approved by your clinician. That is separate from the evaluation-fee policy and does not promise an automatic refund of every program charge. Ask which charges would remain and whether any proposed alternative changes the product, price or delivery expectations.
Does canceling my subscription stop a medication already ordered?
Not by itself. The terms distinguish subscription cancellation from pending prescription, laboratory and appointment transactions. Medication can be canceled for a full refund before the prescription is transmitted to the pharmacy, but becomes nonrefundable afterward. If you want both renewal and an order stopped, request both actions and confirm the order’s status promptly.
Our assessment
Bliv documents several consequential details more clearly than its headline prices suggest: the separation between platform and medical groups, clinician discretion, automatic renewal, evaluation refunds and the pharmacy-transmission cutoff for medication refunds. Those disclosures help a prospective patient ask focused questions rather than relying on broad promises of convenience. The unresolved issues are equally material: the exact prescription, qualifying plan structure, full cost, pharmacy identity before ordering and practical follow-up arrangements. A useful next step is to request one written offer connecting those elements, together with working clinical and cancellation contacts. Bliv’s public documentation supports evaluating it as a GLP-1 telehealth option, but not assuming that the lowest advertised payment describes a complete, suitable or fully specified care package.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.